Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech CEO
Biotech
82% of industry CEOs concerned about FDA's abilities: survey
Biotech CEOs worry that added volatility in an already high-risk industry will discourage investment or will drive it to other countries.
Gabrielle Masson
Nov 21, 2025 4:38pm
Pfizer vet takes CEO post at new, phase 3-ready biotech
Sep 9, 2025 10:03am
Cullinan CEO sets tone for bispecific's upcoming lupus readout
Feb 7, 2025 5:00am
How Vir found the one: CEO Marianne De Backer
Apr 19, 2024 10:27am
After laying off most staff, Acasti insists it's still on track
Jun 23, 2023 8:22am
Teva looks to amp up research collaborations, CEO says
Jan 12, 2023 10:20am
